Document Detail


Low dose intravaginal misoprostol versus intracervical baloon catheter for pre-induction cervical ripening.
MedLine Citation:
PMID:  16167722     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The efficacy and safety of low dose misoprostol as a ripening agent compared to the widely used balloon catheter in developing countries is undetermined. OBJECTIVE: To compare the safety and efficacy of a low dose intravaginal misoprostol and intracervical Foley's catheter for cervical ripening. DESIGN: A prospective randomized controlled trial. SETTING: Zonal General Hospital, Kwale, Nigeria from June 1, 1998 to May 30, 2001. METHODS: Candidates for pre-induction cervical ripening were randomized to receive either 250 mcg of intravaginal misoprostol every four hours (n = 60) or intracervical Foley's catheter (n = 61). MAIN OUTCOME MEASURES: Failure to achieve cervical ripening within 24 hours, need for augmentation, maternal and foetal complications. RESULTS: Failure to achieve cervical ripening within two hours was reduced with misoprostol (Relative Risk [RR] 0.63, 95% Confidence Interval [CI] 0.43 - 0.92). Need for oxytocin augmentation was less in the misoprostol group (RR 0.76, 95% CI 0.64 to 0.91). No significant differences existed in rates for uterine hyperstimulation, Caesarean section, maternal and neonatal morbidity. CONCLUSION: Intravaginal misoprostol in a low dose was compared to intracervical balloon catheter for pre-induction ripening of the cervix.
Authors:
T O Tabowei; V O Oboro
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  East African medical journal     Volume:  80     ISSN:  0012-835X     ISO Abbreviation:  East Afr Med J     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2005-09-19     Completed Date:  2005-11-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372766     Medline TA:  East Afr Med J     Country:  Kenya    
Other Details:
Languages:  eng     Pagination:  91-4     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, Zonal General Hospital, Kwale, Delta State, Nigeria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intravaginal
Adult
Balloon Dilatation / adverse effects,  methods*
Cervical Ripening / drug effects*
Dose-Response Relationship, Drug
Female
Humans
Labor, Induced / methods*
Misoprostol / administration & dosage*,  adverse effects
Obstetric Labor Complications / etiology
Oxytocics / administration & dosage*,  adverse effects
Pregnancy
Pregnancy Outcome
Prospective Studies
Treatment Outcome
Chemical
Reg. No./Substance:
0/Oxytocics; 59122-46-2/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Knowledge, attitudes, and practices of private medical practitioners on tuberculosis among HIV/AIDS ...
Next Document:  CD4T lymphocyte subsets and disease manifestation in children with and without HIV born to HIV-1 inf...